---
figid: PMC10494850__bb-2023-8782f5
pmcid: PMC10494850
image_filename: bb-2023-8782f5.jpg
figure_link: /pmc/articles/PMC10494850/figure/f5/
number: Figure 5
figure_title: ''
caption: 'Graphical abstract. AR: Androgen receptor; AR-V7: Androgen receptor splice
  variant 7; AMPK: 5''AMP adenosine monophosphate-activated protein kinase; ATGs:
  Autophagy-related genes; Bcl-2: B-cell lymphoma; CAFs: Cancer-associated fibroblasts;
  EGF: Epidermal growth factor; EGFR: Epidermal growth factor receptor; HER: Human
  epidermal growth factor receptor; HIFU: High intensity focused ultrasound; IGF:
  Insulin growth factor; MRI: Magnetic resonance imaging; NKX3-1: NK3 Homeobox 1;
  iPARP: Poly (ADP-ribose) polymerase inhibitors; PCA3: Prostate cancer antigen 3;
  PIK3-AKT-mTOR: Phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway;
  PTEN: Phosphatase and tensin homolog; PSA: Prostate specific antigen; TRUS: Transrectal
  ultrasound scan; PSMA-PET: Prostatic specific membrane antigen-positron emission
  tomography; TMPRSS2-ERG: Transmembrane protease serine 2 v-ets to erythroblastosis
  virus E26 fusion; TGF-Î²: Transforming growth factor beta; TMEs: Tumor microenvironment
  immune elements; TNF-R: Tumor necrosis factor receptor; TP53: Tumor suppressor protein
  53; TRAIL: Tumor necrosis factor-ligand apoptosis-inducing ligand; TURP: Transurethral
  resection of the prostate.'
article_title: 'Molecular basis and therapeutic targets in prostate cancer: A comprehensive
  review.'
citation: Florentina Claudia Militaru, et al. Biomol Biomed. 2023 Oct 1;23(5):760-771.
year: '2023'

doi: 10.17305/bb.2023.8782
journal_title: Biomolecules and Biomedicine
journal_nlm_ta: Biomol Biomed
publisher_name: Association of Basic Medical Sciences of Federation of Bosnia and
  Herzegovina

keywords:
- Prostate cancer
- pathways
- genetic syndromes
- targeted therapy

---
